Pharmacodynamic and pharmacokinetic measurements of antitumor agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001830:Body Surface Area; D002455:Cell Division; D006224:Cricetinae; D046508:Culture Techniques; D003520:Cyclophosphamide / Q000378:metabolism; D003561:Cytarabine / Q000627:therapeutic use; D004285:Dogs; D006207:Half-Life; D000882:Haplorhini; D006801:Humans; D007700:Kinetics; D007939:Leukemia L1210 / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000188:drug therapy; D051381:Rats; D013045:Species Specificity; D013997:Time Factors
D000970:Antineoplastic Agents; D003561:Cytarabine; D003520:Cyclophosphamide; D008727:Methotrexate